Mark S. Hanamoto
13Patents
12h-index
12Co-inventors
75Inventor score
Filing activity: Apr 26, 1982 → Jul 13, 2001
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5877216A | Treatment of female sexual dysfunction | Performing Operations; Transporting | 236 | Expired |
| US6294550A | Treatment of female sexual dysfunction | Human Necessities | 222 | Expired |
| US6306841A | Treatment of female sexual dysfunction | Human Necessities | 210 | Expired |
| US6469016B1 | Treatment of female sexual dysfunction using phosphodiesterase inhibitors | Human Necessities | 110 | Expired |
| US5910316A | Use of nitric oxide-releasing agents to treat impotency | Chemistry; Metallurgy | 103 | Expired |
| US6472434B1 | Method for minimizing excess collagen deposition | Human Necessities | 96 | Expired |
| US6593313B2 | Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction | Human Necessities | 66 | Expired |
| US4454232A | Estriol assay | Emerging Cross-Sectional Technologies | 43 | Expired |
| US6290981A | Use of nitric oxide-releasing agents to treat impotency | Chemistry; Metallurgy | 34 | Expired |
| US4409335A | Method for eliminating glucose dependent Schiff base effect from hemoglobin A.sub.1 assay | Emerging Cross-Sectional Technologies | 33 | Expired |
| US4648529A | Dispensing apparatus for storing, draining and dispensing beads | Performing Operations; Transporting | 30 | Expired |
| US4389491A | Method and kit for chromatographic separation of hemoglobin A.sub.1c | Physics | 20 | Expired |
| US5919474A | Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith | Human Necessities | 9 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.